We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TWO:NYSETwo Harbors Investment Corp Analysis

Data as of 2026-08-01 - not real-time

$12.09

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Two Harbors Investment Corp. trades near its 20‑day SMA of $12.09 and just above a key support level at $12, with a modest bullish MACD histogram and an RSI of 42 indicating neutral momentum. The stock offers an eye‑catching 11.25% dividend yield supported by a 76% payout ratio, but trailing EPS is negative while forward EPS turns positive, yielding a forward P/E of 10.27 versus an industry average of 32.37, suggesting the price is undervalued relative to peers. The company’s balance sheet is highly leveraged (debt‑to‑equity ~379) and operating cash flow is modest ($127 M), raising questions about dividend sustainability despite ample cash reserves.
The pending acquisition by CrossCountry Mortgage at $12 per share provides a concrete catalyst that aligns closely with the current market price, potentially delivering a modest premium to shareholders. Low beta (≈0.23) and 30‑day volatility of ~8% point to limited price swings, while increasing volume supports liquidity. However, sector‑specific risks—sensitivity to interest‑rate movements in mortgage REITs—and regulatory considerations temper the outlook, especially given the high leverage and recent negative earnings.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price hovering at technical support/resistance cluster
  • High dividend yield but sustainability concerns
  • Upcoming merger announcement providing near‑term catalyst

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Confirmed $12 per share acquisition premium
  • Forward earnings turning positive with a reasonable P/E
  • Continued dividend payout at attractive yield

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Post‑merger integration and debt reduction outlook
  • Sector exposure to interest‑rate risk
  • Potential for dividend adjustments if cash flow remains constrained

Key Metrics & Analysis

Financial Health

Revenue Growth620.20%
Profit Margin-3.39%
P/E Ratio10.3
ROE-1.19%
ROA-0.20%
Debt/Equity379.40
P/B Ratio1.1
Op. Cash Flow$127.2M
Industry P/E32.4

Technical Analysis

TrendNeutral
RSI41.8
Support$12.00
Resistance$12.14
MA 20$12.09
MA 50$12.26
MA 200$11.21
MACDBullish
VolumeIncreasing
Fear & Greed Index92.88

Valuation

Target Price$11.91
Upside/Downside-1.53%
GradeUndervalued
TypeValue
Dividend Yield11.25%

Risk Assessment

Beta0.23
Volatility8.00%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.